SPH Notice – Hikurangi Bioactives Ltd & Hikurangi Bioactive

1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
To NZX Limited (NZX)
and
To Rua Bioscience Limited (Rua)
Relevant event being disclosed: Movement of 1% or more in the substantial holding
Date of relevant event: 4 June 2021
Date this disclosure made: 8 June 2021
Date last disclosure made: 22 October 2020
Substantial product holder(s) giving disclosure
Full name(s): Hikurangi Bioactives Limited Partnership (HBLP) and Hikurangi Bioactives GP
Limited (HBGPL)
Summary of substantial holding
Class of quoted voting products: ordinary shares in Rua
Summary for HBLP and HBGPL
For this disclosure,—
(a) total number held in class: 17,616,591
(b) total in class: 140,262,591
(c) total percentage held in class: 12.58%
For last disclosure,—
(a) total number held in class: 23,488,787
(b) total in class: 140,012,225
(c) total percentage held in class: 16.776%
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure:
•
The dates of the beginning and end of the period of the aggregated on market and
off market trades are 19 March 2021 and 4 June 2021.
•
The nature of the transactions is on-market and off-market sale of the shares.
•
The total consideration received for aggregated on-market trades is NZ$568,740.80
(before fees) for 1,380,000 ordinary shares in Rua.

2
•
The total consideration received for aggregated off-market trades is
NZ$1,662,112.00 (before fees) for 4,492,196 ordinary shares in Rua.
•
The total number of ordinary shares in Rua to which the aggregated on-market and
off-market trades related is 5,872,196.
Details after relevant event
Details for HBLP
Nature of relevant interest(s): Registered holder and beneficial owner of the shares
For that relevant interest,—
(a) number held in class: 17,616,591
(b) percentage held in class: 12.58%
(c) current registered holder(s): HBLP
(d) registered holder(s) once transfers are registered: unknown
For a derivative relevant interest, also—
(a) type of derivative: Not applicable
(b) details of derivative: Not applicable
(c) parties to the derivative: Not applicable
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: Not applicable
Details for HBGPL
Nature of relevant interest(s): HBGPL has the responsibility, authority and power for the
management and control of the business and affairs of HBLP as its general partner, and
accordingly has a relevant interest in HBLP’s shares in Rua.
For that relevant interest,—
(a) number held in class: 17,616,591
(b) percentage held in class: 12.58%
(c) current registered holder(s): HBLP
(d) registered holder(s) once transfers are registered: unknown
For a derivative relevant interest, also—
(a) type of derivative: Not applicable
(b) details of derivative: Not applicable

3
(c) parties to the derivative: Not applicable
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: Not applicable
Additional information
Address(es) of substantial product holder(s):
•
HBLP: 6434 Waiapu Road, Rd 1, Ruatoria, 4081, New Zealand
•
HBGPL: c/o Coates Associates Limited, 300 Childers Road, Gisborne, Gisborne,
4010, New Zealand
Contact details: Damian Skinner, damian@hikurangibioactives.co.nz, Tel.
021526870
Nature of connection between substantial product holders: HBLP and HBGPL are associated
persons under section 12(1) of the Financial Markets Conduct Act 2013.
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: Manu Caddie
Certification
I, Damian Hugh Skinner, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.